Bristol-Myers (NYSE:BMY) reported Q4 EPS of $0.47, ex-items, in line with consensus estimates.
AeroVironment (AVAV) says it received an order valued at $4,862,674 under a contract with the Norwegian...
Donald Allan Jr, Senior Vice President and CFO commented, "I am very pleased with our 2010 financial performance for it sets the stage for what is ahead. While our acquisition track record is solid and the pipeline is robust, our
Stanley Black & Decker (NYSE:SWK) reported Q4 $1.05, ex-items, ahead of consensus estimates of $0.92 per share. Revenues for the quarter rose 149% year-over-year to $2.41 billion, topping consensus estimates of $2.38 billion.
The company expects 2011 capex of $1.4 billion. Coal production guidance for 2011 is maintained at between 59 and 61 million tons.
Coal producer Consol Energy (NYSE:CNX) reported adjusted Q4 EPS of 54 cents, falling short of analyst estimates of 56 cents. Revenue rose to $1.34 billion, also below the $1.39 billion analysts were projecting.
William H. Swanson, Raytheon's Chairman and CEO said, "Raytheon's focus on performance drove solid operating results, The depth and breadth of our product portfolio coupled with outstanding execution positions the company well goi
Raytheon (NYSE:RTN) reported adjusted Q4 EPS of $1.57 and earnings from continuing operations of $1.25 per share. On average, analysts expected EPS of $1.16. Revenues for the quarter rose 3% to $6.90 billion, missing consensus est
The company said it sees Q3 sales growth of 5-7% (vs. 4.9% estimate) and sees Q3 core EPS of $0.95-$1.00 vs. a $0.99 estimate.
P&G reaffirmed its full-year guidance and sees core EPS growth of 7-9% and sees total sales up 3-5% with organic sales growth of 4-6%. Analysts are looking for sales growth of 4.4%.
Procter & Gamble (NYSE:PG) reported fiscal Q2 core EPS of $1.13, above the consensus estimate of $1.10. Revenue rose to $21.35 billion but fell short of analyst estimates of $21.57 billion.
The company said it sees 2011 EPS up 10-12% or around $1.67-$1.70. That compares to analyst estimates of $1.69. Newell also said that core sales should rise 4-5% in 2011 which is above analysts projects for a 3.7% rise.
President and CEO Mark Ketchum said, "We finished out 2010 with very positive fourth quarter results.
Newell Rubbermaid (NYSE:NWL) reported Q4 EPS of 34 cents, ex-items, topping estimates of 32 cents per share. Revenue rose to $1.47 billion which was also better than the Street estimates of $1.45 billion.
The company reported that Humalog sales rose 3% to $549.1 million and Zyprexa sales fell 2% to $1.34 billion.
Eli Lilly said it expects 2011 EPS of $4.14-$4.30 which, at the midpoint, is below the consensus view of $4.32. The company also expects total revenue growth will be flat to slightly increasing. The company anticipates that the im
Eli Lilly (NYSE:LLY) reported Q4 adjusted EPS of $1.11, a penny better than the $1.10 per share analyst were anticipating. Revenue rose to $6.19 billion which was also better than the $5.99 billion Street estimate.
You did not create any Kaltura items